Neuromodulation Market 2025 to 2034
Neuromodulation Market 2025 to 2034
Neuromodulation Market (By Technology: Internal Neuromodulation, External Neuromodulation; By Application: Chronic Pain, Urinary and Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications; By Biomaterials: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 9.07
Forecast Year, 2034
USD 25.51
CAGR, 2025 - 2034
12.17%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global neuromodulation market, valued at USD 9.07 billion in 2025, is projected to reach USD 25.51 billion by 2034, growing at a robust CAGR of 12.17%, driven by rising neurological disorders and technological advancements in therapy devices
Neuromodulation Market Size Analysis
Neuromodulation Market Size By Drug Type 2025 to 2034 (USD Billion)
| Drug Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics Drugs | 0.91 | 1.02 | 1.14 | 1.28 | 1.44 | 1.61 | 1.83 | 2.03 | 2.29 | 2.57 |
| Antifungal Drugs | 1.81 | 2.04 | 2.28 | 2.57 | 2.87 | 3.23 | 3.63 | 4.06 | 4.56 | 5.12 |
| Antiviral Drugs | 2.73 | 3.05 | 3.43 | 3.84 | 4.31 | 4.82 | 5.40 | 6.08 | 6.83 | 7.63 |
| Others | 3.63 | 4.06 | 4.56 | 5.12 | 5.74 | 6.44 | 7.21 | 8.10 | 9.06 | 10.17 |
Neuromodulation Market Size By Applications 2025 to 2034 (USD Billion)
| Applications | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bloodstream Infections | 0.43 | 0.49 | 0.55 | 0.62 | 0.69 | 0.77 | 0.87 | 0.98 | 1.08 | 1.22 |
| Pneumonia | 0.87 | 0.97 | 1.09 | 1.22 | 1.37 | 1.54 | 1.73 | 1.94 | 2.17 | 2.44 |
| Surgical Site Infections | 1.30 | 1.45 | 1.64 | 1.83 | 2.05 | 2.30 | 2.58 | 2.89 | 3.25 | 3.64 |
| Urinary Tract Infections | 1.72 | 1.94 | 2.18 | 2.44 | 2.73 | 3.07 | 3.44 | 3.86 | 4.33 | 4.86 |
| Gastrointestinal Disorders | 2.16 | 2.42 | 2.71 | 3.04 | 3.42 | 3.84 | 4.30 | 4.82 | 5.40 | 6.05 |
| Other Hospital Infections | 2.59 | 2.91 | 3.25 | 3.65 | 4.09 | 4.59 | 5.16 | 5.78 | 6.50 | 7.29 |
Neuromodulation Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.91 | 1.01 | 1.15 | 1.28 | 1.45 | 1.63 | 1.82 | 2.03 | 2.27 | 2.57 |
| LAMEA | 1.82 | 2.04 | 2.28 | 2.57 | 2.86 | 3.23 | 3.60 | 4.08 | 4.57 | 5.11 |
| Europe | 2.72 | 3.05 | 3.43 | 3.84 | 4.31 | 4.81 | 5.42 | 6.07 | 6.82 | 7.63 |
| Asia-Pacific | 3.62 | 4.07 | 4.55 | 5.12 | 5.74 | 6.44 | 7.22 | 8.09 | 9.07 | 10.18 |
Neuromodulation Market Size to Hit USD 25.51 Billion by 2034
The global neuromodulation market size is calculated at USD 9.07 billion in 2025 and is predicted to attain around USD 25.51 billion by 2034 with a expanding at a CAGR of 12.17%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
